✦ LIBER ✦

Collamer intraocular lens: clinical results from the U.S. FDA core study

✍ Scribed by David C Brown; Steven L Ziémba

Book ID: 117584995
Publisher: Elsevier Science
Year: 2001
Tongue: English
Weight: 476 KB
Volume: 27
Category: Article
ISSN: 0886-3350
DOI: 10.1016/s0886-3350(01)00785-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Clinical evaluation of the Crystalens AT

Clinical evaluation of the Crystalens AT-45 accommodating intraocular lens: Results of the U.S. Food and Drug Administration clinical trial

✍ J. Stuart Cumming; D. Michael Colvard; Steven J. Dell; John Doane; I. Howard Fin 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 644 KB

Predictability of Intraocular Lens Power

Predictability of Intraocular Lens Power Calculation Formulae in Infantile Eyes With Unilateral Congenital Cataract: Results From the Infant Aphakia Treatment Study

✍ Cooke, David L. 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 55 KB

Pivotal, randomized U.S. study of the Sy

Pivotal, randomized U.S. study of the Symbiot™ covered stent system in patients with saphenous vein graft disease: Eight-month angiographic and clinical results from the Symbiot III trial

✍ Mark A. Turco; Maurice Buchbinder; Jeffrey J. Popma; Neil J. Weissman; Tift Mann 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 219 KB 👁 2 views

Can multiparametric magnetic resonance i

Can multiparametric magnetic resonance imaging predict upgrading of transrectal ultrasound biopsy results at more definitive histology?11Mohamed Abd-Alazeez receives funding from the Egyptian government. Mark Emberton and Hashim U. Ahmed receive funding from USHIFU and Advanced Medical Diagnostics for clinical trials. Mark Emberton is a paid consultant for Steba Biotech, USHIFU and Sanofi-Aventis. Mark Emberton has received research support by GSK for a study evaluating the role of MRI in men with prostate cancer. Mark Emberton and Hashim Ahmed have previously received medical consultancy fees from GE Healthcare/Oncura and Hashim Ahmed previously from Steba Biotech. Mark Emberton is a medical director of Mediwatch PLC. Hashim Uddin Ahmed and Mark Emberton receive funding from the Medical Research Council, the NIHR-HTA, NIHR-i4i, the US NIH/NCI, Pelican Cancer Foundation, Prostate Cancer UK, and St Peter׳s Trust. This work was part funded by research support for Mark Emberton and Alex Kirkham from the UK National Institute of Health Research UCLH/UCL Comprehensive Biomedical Research Centre, London, UK.

✍ Abd-Alazeez, Mohamed; Ahmed, Hashim U.; Arya, Manit; Allen, Clare; Dikaios, Niko 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 415 KB